When we further sub-classified the CH group based on CSF amyloid and total Tau levels to distinguish those CH individuals at higher risk of developing AD, we identified three groups using pattern of CH-NAT, CH-PAT, and AD. This evidence concerns the gene BRD2 and Alzheimer disease.